Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Stress Management and Multiple Sclerosis: A Randomized Controlled Trial.
Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis.
High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases.
No impact of adult attachment and temperament on clinical variability in patients with clinically isolated syndrome and early multiple sclerosis.
A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ß-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) (LIBRETTO)
Puma, but not noxa is essential for oligodendroglial cell death.
Disrupted balance of T cells under natalizumab treatment in multiple sclerosis.
Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis.
Dopaminergic Modulation of CD4+CD25 Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-β Therapy.
Takeda Submits a New Drug Application for Glatiramer Acetate in Japan for the Relapse Prevention of Multiple Sclerosis
Glatiramer acetate and interferon-beta throughout gestation and postpartum in women with multiple sclerosis.
Roche's new time-saving subcutaneous formulation of MabThera approved in Europe for the treatment of common forms of non-Hodgkin Lymphoma
Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration.
Pediatric multiple sclerosis.
Substance Name: Amiloride
Effect of glatiramer acetate three-times weekly on the evolution of new, active multiple sclerosis lesions into T1-hypointense "black holes": a post hoc magnetic resonance imaging analysis.
The Many Facets of Cell Injury: Angiogenesis to Autophagy.
[Infections and fingolimod].
Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.
Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis.
Small internal jugular veins with restricted outflow are associated with severe multiple sclerosis: a sonographer-blinded, case--control ultrasound study.
Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.
Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis.
Takeda Pharmaceutical: New Drug Application Approval in Japan for Copaxone® Subcutaneous Injection 20 mg Syringe, a Drug for the Treatment of Multiple Sclerosis
Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats.

Pages